Northstar Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Northstar Wealth Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$886K	Sell	14,697 -20	-0.1%	-$1.2K	0.41%	64
2020 Q2	$865K	Sell	14,717 -443	-3%	-$26.5K	0.36%	78
2020 Q1	$845K	Sell	15,160 -3,910	-21%	-$239K	0.43%	69
2019 Q4	$1.22M	Buy	+19,070	New	+$1.09M	0.5%	66
2019 Q3	–	Sell	-11,517	Closed	-$522K	–	179
2019 Q2	$522K	Sell	11,517 -882	-7%	-$41.1K	0.23%	108
2019 Q1	$592K	Sell	12,399 -47	-0.4%	-$2.34K	0.27%	100
2018 Q4	$647K	Sell	12,446 -100	-0.8%	-$5.37K	0.34%	83
2018 Q3	$778K	Sell	12,546 -3,164	-20%	-$188K	0.37%	77
2018 Q2	$869K	Buy	15,710 +346	+2%	+$18.7K	0.44%	73
2018 Q1	$971K	Buy	15,364 +8,985	+141%	+$578K	0.5%	64
2017 Q4	$395K	Sell	6,379 -137	-2%	-$8.57K	0.35%	87
2017 Q3	$418K	Sell	6,516 -743	-10%	-$43.4K	0.41%	81
2017 Q2	$405K	Sell	7,259 -439	-6%	-$23.9K	0.37%	82
2017 Q1	$409K	Buy	+7,698	New	+$422K	0.38%	82

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Northstar Wealth Partners's BMY Position: Q3 2020 in Review

Northstar Wealth Partners reduced its Bristol-Myers Squibb (BMY) stake by 0.14% in Q3 2020, selling an estimated $1.2K and leaving 14,697 shares worth $886K. The position accounts for 0.41% of the portfolio, ranked #64.

Northstar Wealth Partners first reported a position in BMY in Q1 2017 and has held it in 14 quarters since. The position peaked at $1.22M in Q4 2019. 2,215 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

Northstar Wealth Partners held 14,697 shares of Bristol-Myers Squibb worth $886K as of Q3 2020.
Northstar Wealth Partners sold 20 Bristol-Myers Squibb shares in Q3 2020, an estimated $1.2K.
Bristol-Myers Squibb made up 0.41% of Northstar Wealth Partners's portfolio in Q3 2020, its #64 holding.
Northstar Wealth Partners first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 14 quarters since.
Northstar Wealth Partners's Bristol-Myers Squibb position peaked at $1.22M in Q4 2019.
2,215 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on Northstar Wealth Partners's 13F filing for Q3 2020, filed 13 Nov 2020.